Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|March 5, 2002
p53 as a potential predictive factor of response to chemotherapy: feasibility of p53 assessment using a functional test in yeast from trucut biopsies in breast cancer patientsH Bonnefoi, A Ducraux, S Movarekhi, et al.
Diagnostic and Interventional Imaging|July 23, 2013
Correlation between imaging and molecular classification of breast cancersM Boisserie-Lacroix, G Hurtevent-Labrot, S Ferron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Functional evaluation of plasmin formation in primary breast cancerP O Chappuis, B Dieterich, V Sciretta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2001
Infusional ECarboF in patients with advanced breast cancer: a very active and well-tolerated out-patient regimenA Hügli, A P Sappino, S Anchisi, et al.
International Journal of Cancer|November 24, 1999
Prognostic significance of p53 mutation in breast cancer: frequent detection of non-missense mutations by yeast functional assayP O Chappuis, A Estreicher, B Dieterich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancerX Chen, H Bonnefoi, S Diebold-Berger, et al.
Breast Cancer Research and Treatment|April 26, 2012
Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicityM Toulmonde, N Madranges, V Brouste, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Natural history of stage IV epithelial ovarian cancerH Bonnefoi, R P A'Hern, C Fisher, et al.
British Journal of Cancer|April 7, 1998
Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trialsC Hürny, B van Wegberg, M Bacchi, et al.
British Journal of Cancer|February 1, 1996
Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimenH Bonnefoi, I E Smith, M E O'Brien, et al.
Pageof 5